
Telomir Pharmaceuticals, Inc. Common Stock
TELOHealthcare|Biotechnology|US
$0.71
-0.07 (-8.97%)
DCF Value
$0.20
Tangible Book / Share
$0.06
Cash / Share
$0.07
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Nov 5, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
Oct 29, 2026 · Newsfile Corp
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
Oct 6, 2026 · GlobeNewsWire
Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
Sep 29, 2026 · Newsfile Corp
SEC Filings (82)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | EFFECT | DocumentIndex | |
| Nov 5, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 27, 2026 | S-3 | Shelf registration | DocumentIndex |
| Oct 6, 2026 | 8-K | Material event | DocumentIndex |
| Sep 17, 2026 | 8-K | Material event | DocumentIndex |
| Sep 16, 2026 | 8-K | Material event | DocumentIndex |
| Sep 14, 2026 | 8-K | Material event | DocumentIndex |
| Aug 19, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Jun 15, 2026 | 8-K | Material event | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| May 20, 2026 | 8-K | Material event | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 30, 2026 | 8-K | Material event | DocumentIndex |
| Apr 24, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 27, 2026 | 8-K | Material event | DocumentIndex |
| Mar 17, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 19, 2026 | DEFM14A | Proxy / shareholder vote | DocumentIndex |
| Feb 19, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Feb 17, 2026 | 8-K | Material event | DocumentIndex |
| Feb 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 5, 2026 | 8-K | Material event | DocumentIndex |
| Feb 5, 2026 | PRER14A | DocumentIndex | |
| Jan 23, 2026 | PRER14A | DocumentIndex | |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | 8-K | Material event | DocumentIndex |
| Dec 22, 2025 | 8-K | Material event | DocumentIndex |
| Dec 17, 2025 | 8-K | Material event | DocumentIndex |
| Nov 28, 2025 | PRER14A | DocumentIndex | |
| Nov 24, 2025 | 8-K | Material event | DocumentIndex |
| Nov 20, 2025 | 8-K | Material event | DocumentIndex |
| Nov 20, 2025 | PREM14A | DocumentIndex | |
| Nov 20, 2025 | 8-K | Material event | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |